Intraoperative touch imprint cytology of axillary sentinel nodes for breast cancer: A series of 355 procedures

Breast

Volumn 20, Issue 2, 2011, Pages 119-123

  Lorand, Sophie ^a,b   Lavoué, Vincent ^a   Tas, Patrick ^b   Foucher, Fabrice ^a,b   Mesbah, Habiba ^b   Rouquette, Sophie ^a,b   Bendavid, Cécile ^b   Coué, Olivier ^b   Porée, Philippe ^b   Leveque, Jean ^a,b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Eugene Marquis Comprehensive Cancer Center   (France)

Author keywords

Breast cancer; Cytology; Intraoperative examination; Micrometastasis; Sentinel node

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LUNG CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; MICROMETASTASIS; MOLECULAR IMPRINTING; PEROPERATIVE CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; VALIDATION PROCESS;

EID: 79952626219     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.08.004     Document Type: Article

References (31)

1. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol Oct 20 2005, 23(30):7703-7720.
2. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet Jun 28 1997, 349(9069):1864-1867.
3. Cox C., Centeno B., Dickson D., et al. Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma. Cancer Feb 25 2005, 105(1):13-20.
4. Tew K., Irwig L., Matthews A., Crowe P., Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg Sep 2005, 92(9):1068-1080.
5. Chao C., Wong S.L., Ackermann D., et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am J Surg Dec 2001, 182(6):609-615.
6. Tamaki Y., Akiyama F., Iwase T., et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res Apr 15 2009, 15(8):2879-2884.
7. Visser M., Jiwa M., Horstman A., et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer Jun 1 2008, 122(11):2562-2567.
8. D'Halluin F., Tas P., Rouquette S., et al. Intra-operative touch preparation cytology following lumpectomy for breast cancer: a series of 400 procedures. Breast Aug 2009, 18(4):248-253.
9. HAS. Recommandations pour la Pratique Clinique - Cancers du sein. Consensus de Saint Paul de Vence. Available from: 2005. http://www.has.fr.
10. Schwartz G.F., Giuliano A.E., Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer May 15 2002, 94(10):2542-2551.
11. McCarter M.D., Yeung H., Fey J., Borgen P.I., Cody H.S. The breast cancer patient with multiple sentinel nodes: when to stop?. J Am Coll Surg Jun 2001, 192(6):692-697.
12. Dufour P., Laurent J.C., Depadt G., Demaille A. Cancer du sein: peut-on se limiter aux etages 1 et 2 de Berg, lors du curage axillaire? Etude a propos de 895 cas. J Gynecol Obstet Biol Reprod (Paris) 1991, 20(2):171-177.
13. Singletary S.E., Greene F.L. Revision of breast cancer staging: 6th edition of the TNM classification. Semin Surg Oncol 2003, 21(1):53-59.
14. Zgajnar J., Frkovic-Grazio S., Besic N., et al. Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients-results of a large series. J Surg Oncol Feb 2004, 85(2):82-86. discussion 87.
15. Motomura K., Nagumo S., Komoike Y., Koyama H., Inaji H. Accuracy of imprint cytology for intraoperative diagnosis of sentinel node metastases in breast cancer. Ann Surg May 2008, 247(5):839-842.
16. Creager A.J., Geisinger K.R., Perrier N.D., et al. Intraoperative imprint cytology evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg Jan 2004, 239(1):61-66.
17. Capdet J., Martel P., Charitansky H., et al. Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 cases. Eur J Surg Oncol Jun 30 2009.
18. Rivadeneira D.E., Simmons R.M., Christos P.J., Hanna K., Daly J.M., Osborne M.P. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg Jul 2000, 191(1):1-6. discussion 6-8.
19. Laplanche AC-NC, Flamant R., editors. Méthodes statistiques appliquées à la recherche clinique. Paris: Flammarion; ed1987.
20. Yankaskas B.C. Epidemiology of breast cancer in young women. Breast Dis Sep 3 2009, 23:3-8.
21. Silverstein M.J., Lewinsky B.S., Waisman J.R., et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?. Cancer Mar 15 1994, 73(6):1673-1677.
22. Molland J.G., Donnellan M., Janu N.C., Carmalt H.L., Kennedy C.W., Gillett D.J. Infiltrating lobular carcinoma-a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast Oct 2004, 13(5):389-396.
23. Moll R., Mitze M., Frixen U.H., Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol Dec 1993, 143(6):1731-1742.
24. van Deurzen C.H., de Bruin P.C., Koelemij R., Hillegersberg R., van Diest P.J. Isolated tumor cells in breast cancer sentinel lymph nodes: displacement or metastases? An immunohistochemical study. Hum Pathol Jun 2009, 40(6):778-782.
25. Reed J., Rosman M., Verbanac K.M., Mannie A., Cheng Z., Tafra L. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg Mar 2009, 208(3):333-340.
26. de Boer M., van Deurzen C.H., van Dijck J.A., et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med Aug 13 2009, 361(7):653-663.
27. Gajdos C., Tartter P.I., Bleiweiss I.J. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg Nov 1999, 230(5):692-696.
28. Barth A., Craig P.H., Silverstein M.J. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer May 15 1997, 79(10):1918-1922.
29. Olivotto I.A., Jackson J.S., Mates D., et al. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis. Cancer Sep 1 1998, 83(5):948-955.
30. Swart G.J., Wright C., Brundyn K., et al. Fine needle aspiration biopsy and flow cytometry in the diagnosis of lymphoma. Transfus Apheresis Sci Aug 2007, 37(1):71-79.
31. Martin Martinez M.D., Veys I., Majjaj S., et al. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes. Eur J Surg Oncol Apr 2009, 35(4):387-392.